{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:29:50Z","timestamp":1789997390772,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ijpharm.2011.04.053","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T01:56:37Z","timestamp":1304214997000},"page":"147-154","source":"Crossref","is-referenced-by-count":24,"title":["Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology"],"prefix":"10.1016","volume":"413","author":[{"given":"AJ.","family":"Baxendale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Hooff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Spendlove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Howdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Illum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.04.053_bib0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/03639040701377847","article-title":"Chitosan microparticles as oral delivery system for tetanus toxoid","volume":"33","author":"Ahire","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5173(00)00363-X","article-title":"Parameters influencing the antigen release from spray-dried poly(dl-lactide) microparticles","volume":"200","author":"Baras","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/11539070-000000000-00000","article-title":"Systemic and mucosal delivery of drugs within polymeric microparticles produced by spray drying","volume":"24","author":"Bowey","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.addr.2006.12.001","article-title":"Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering","volume":"60","author":"Davies","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0030","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralising antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2006.01.012","article-title":"Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres","volume":"112","author":"Feng","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1039\/b008188o","article-title":"Supercritical fluid mixing: preparation of polymer composites containing bioactive materials","author":"Howdle","year":"2001","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0169-409X(01)00173-9","article-title":"Polymeric lamellar substrate particles for intranasal vaccination","volume":"51","author":"Jabbal-Gill","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.12.026","article-title":"Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres","volume":"294","author":"Jaganathan","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0055","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp800027f","article-title":"Stabilisation of tetanus toxoid encapsulated in PLGA microspheres","volume":"5","author":"Jiang","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jianga","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0065","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.vaccine.2006.01.066","article-title":"Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum","volume":"24","author":"Katare","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejps.2006.01.010","article-title":"Influences of excipients on in vitro release and in vitro performance of tetanus toxoid loaded polymer particles","volume":"28","author":"Katare","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jbm.a.30545","article-title":"Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism","volume":"76","author":"Kipper","year":"2006","journal-title":"J. Biomed. Mat. Res. Part A"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0100-879X1999000200005","article-title":"Poly-dl-lactide-co-glycolide microspheres as a controlled release antigen delivery system","volume":"32","author":"Lima","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohana","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"O\u2019Hagan","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(02)00342-3","article-title":"Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants","volume":"245","author":"Raghuvanshi","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/107175401750177089","article-title":"Formulation and characterisation of immunoreactive tetanus toxoid biodegradable polymer particles","volume":"8","author":"Raghuvanshi","year":"2001","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"Reddy","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0110","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0115","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jps.10042","article-title":"Pharmaceutical and immunological evaluation of a single shot hepatitis B vaccine formulated with PLGA microspheres","volume":"91","author":"Shi","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/14760584.6.5.797","article-title":"Nanoparticles and microparticles as vaccine-delivery systems","volume":"6","author":"Singh","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0264-410X(97)80912-7","article-title":"Controlled release microparticles as a single dose Diphtheria toxoid vaccine: immunogenicity in small animal models","volume":"16","author":"Singh","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0135","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.1021\/bi0011678","article-title":"Characterization of high-order diphtheria toxin oligomers","volume":"39","author":"Steere","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0140","first-page":"293","article-title":"Strategies for stabilising tetanus toxoid towards the development of a single dose tetanus vaccine","volume":"87","author":"Schwendeman","year":"1996","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.supflu.2007.03.001","article-title":"Near-critical fluid micronization of stabilised vaccines antibiotics and anti-virals","volume":"42","author":"Sieverrs","year":"2007","journal-title":"J. Supercrit. Fluid"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2008.03.036","article-title":"Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres","volume":"360","author":"Tabassi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1026498209874","article-title":"Protein instability in poly(lactic-co-glycolic acid) microparticles","volume":"17","author":"van de Weert","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2011.04.053_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2004.07.017","article-title":"The production of protein loaded microparticles by supercritical fluid enhanced mixing and spraying","volume":"101","author":"Whitaker","year":"2005","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T19:09:41Z","timestamp":1592507381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311003802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0378517311003802"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.053","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}